These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5539748)

  • 1. Cis-1-[(2-piperidinocyclohexyl)carbonyl]-piperidine and related compounds. Oral hypoglycemic agents.
    Rynbrandt RH; Schmidt FL
    J Med Chem; 1971 Jan; 14(1):54-6. PubMed ID: 5539748
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoglycemic cyclic amidines.
    Barsky LI; Bencze WL
    J Med Chem; 1971 Jan; 14(1):40-4. PubMed ID: 5539744
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basic pharmacological research on the hypoglycemic action of N-4-[beta-(2-methoxy-5-chlorbenzamide)-ethyl]-benzosulfonyl-N'-cyclohexylurea (Glybenclamide)].
    Dessi P
    Acta Diabetol Lat; 1969; 6(2):206-21. PubMed ID: 5407885
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoglycemic esters of 2-chloroethanol.
    Siggins JE; Harding HR; Potts GO
    J Med Chem; 1969 Sep; 12(5):941-3. PubMed ID: 5812228
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
    Duhault J; Boulanger M; Tisserand F; Bergi L
    Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
    [No Abstract]   [Full Text] [Related]  

  • 6. Quaternary oxazolylpyridinium salts. Oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1969 Sep; 12(5):943-4. PubMed ID: 5812229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 8. cis-1-(2-(p-anisidinomethyl)cyclohexyl)piperidine and related compounds. Oral hypoglycemic agents.
    Rynbrandt RH; Schmidt FL; Szmuszkovicz J
    J Med Chem; 1971 Oct; 14(10):985-7. PubMed ID: 5115700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].
    Hasselblatt A; Panten U; Poser W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1483-7. PubMed ID: 5394471
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 11. 4-Azolylpyridine 1-oxides. Analogs of the hypoglycemic 4-azolylpyridinium salts.
    Bauer VJ; Fanshawe WJ; Wiegand GE; Safir SR
    J Med Chem; 1969 Sep; 12(5):945-6. PubMed ID: 5812231
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycemic quaternary azolylpyridinium salts. Inactive analogs.
    Bauer VJ; Wiegand GE; Fanshawe WJ; Safir SR
    J Med Chem; 1969 Sep; 12(5):944-5. PubMed ID: 5812230
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E; Gey KF; Sommer P
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and pharmacological activity of 1-(arylsulfonyl)-3,5-dialkyl-s-triazine-2,4,6-(1H,3H,5H)-triones.
    Holcomb GN; Klemm LA; Silhavy TJ; Counsell RE
    J Pharm Sci; 1973 Aug; 62(8):1379-81. PubMed ID: 4725196
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-substituted benzenesulfonylureas as hypoglycemic agents.
    Shah MH; Darnule TV; Anantanarayanan KG; Deliwala CV
    J Med Chem; 1969 Sep; 12(5):938-9. PubMed ID: 5812226
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.
    Fuhlendorff J; Rorsman P; Kofod H; Brand CL; Rolin B; MacKay P; Shymko R; Carr RD
    Diabetes; 1998 Mar; 47(3):345-51. PubMed ID: 9519738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of some novel analogues of 4-(1-Pyrrolidinyl) Piperidine and their effect on plasma glucose level.
    Mushtaq N; Saify ZS; Akhtar S; Arif M; Haider S; Saba N
    Pak J Pharm Sci; 2010 Apr; 23(2):220-3. PubMed ID: 20363703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin liberation from the pancreas by sulfonylurea].
    Pfaff W; Schöne HH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.